Andreas Klein
Impact in
- Hepatology top 10%
- Hepatitis C virus research
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
-
- RNA Interference and Gene Delivery 4
- Oncology 10
- Cancer-related Molecular Pathways 5
- Co-authors
- Oded Meyuhas (1 shared paper)Cara Reiter–Brennan (2 shared papers)A. Graessmann (6 shared papers)M. Graessmann (6 shared papers)Daniel Shouval (2 shared papers)Eithan Galun (2 shared papers)Folke Schriever (2 shared papers)Norbert Arnold (3 shared papers)
- Journals
- BMC Cancer (3 papers)Oncogene (2 papers)Glycobiology (2 papers)Clinical Epigenetics (1 paper)Virus Research (1 paper)
- Partner nations
- GermanyUnited StatesIsrael
In The Last Decade
Andreas Klein
39 papers receiving 915 citations
Peers
Comparison fields: 5 of 91
- Hepatology 111
- Cancer Research 160
- Oncology 222
- Genetics 81
- Molecular Biology 445
Countries citing papers authored by Andreas Klein
This map shows the geographic impact of Andreas Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Klein more than expected).
Fields of papers citing papers by Andreas Klein
This network shows the impact of papers produced by Andreas Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Klein. The network helps show where Andreas Klein may publish in the future.
Co-authors
The 25 scholars most cited alongside Andreas Klein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 88 | |
| 2 | 1990 | 85 | |
| 3 | 2001 | 64 | |
| 4 | 2000 | 53 | |
| 5 | 1997 | 50 | |
| 6 | 2006 | 45 | |
| 7 | 2018 | 43 | |
| 8 | 2019 | 38 | |
| 9 | 2009 | 37 | |
| 10 | 2004 | 37 | |
| 11 | 2003 | 37 | |
| 12 | 2009 | 36 | |
| 13 | 2007 | 26 | |
| 14 | 2005 | 26 | |
| 15 | 2010 | 24 | |
| 16 | 2001 | 22 | |
| 17 | Liver transplantation for alcoholic liver disease. | 1996 | 20 |
| 18 | 1988 | 19 | |
| 19 | 2021 | 19 | |
| 20 | Normal mammary fibroblasts induce reversion of the malignant phenotype in human primary breast cancer. | 2013 | 19 |
About Andreas Klein
Andreas Klein is a scholar working on Molecular Biology, Oncology, Cancer Research, Epidemiology and Genetics, having authored 39 papers that have together received 932 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (6 papers), Cancer Genomics and Diagnostics (5 papers), Cancer-related Molecular Pathways (5 papers), RNA Interference and Gene Delivery (4 papers), Hepatitis C virus research (4 papers), Galectins and Cancer Biology (3 papers), Cancer Research and Treatments (3 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Hepatology (111 citations), Cancer Research (160 citations), Oncology (222 citations), Genetics (81 citations) and Molecular Biology (445 citations). Andreas Klein has collaborated with scholars based in Germany, United States and Israel. Frequent co-authors include Oded Meyuhas, Cara Reiter–Brennan, A. Graessmann, M. Graessmann, Daniel Shouval, Eithan Galun, Folke Schriever, Norbert Arnold, Oliver Miera and Sven Golfier. Their work appears in journals such as BMC Cancer, Oncogene, Glycobiology, Clinical Epigenetics and Virus Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.